The document discusses signal detection in pharmacovigilance, defining a signal as information suggesting a potential causal relationship between an adverse event and a drug that necessitates further investigation. It emphasizes traditional methods like individual case reviews and aggregate analysis, along with data mining algorithms as modern techniques for detecting safety signals from adverse reaction data. The primary goal of signal detection is to identify and describe suspected harms related to medication use, drawing evidence from spontaneous reports and other sources.